Core Laboratories price target lowered to $13 from $15 at Stifel

Stifel analyst Stephen Gengaro lowered the firm’s price target on Core Laboratories (CLB) to $13 from $15 and keeps a Hold rating on the shares after the company delivered “mixed” Q1 results. Growth in Production Enhancement was offset by sluggish Reservoir Description performance, says the firm, which expects second half results to be similar to the first half due to macro uncertainty, tariffs, and oil prices.